CONVENING NOTICE – EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)

LUND, SWEDEN, Oct. 27, 2023 /PRNewswire/ — Immunovia AB (publ), reg. no. 556730-4299 (the “Company“), hereby gives notice that an extraordinary general meeting will take place on Tuesday 21st November 2023 at 10.00 in the Company’s offices at Medicon Village, Scheeletorget 1, Lund. Registration to the extraordinary general meeting starts at 09:45.  Notice/Right to participate at … Read more

Chief Executive Officer, Jeff Borcherding, buys Immunovia shares

LUND, Sweden, June 9, 2023 /PRNewswire/ — Immunovia AB (Nasdaq: IMMNOV) announces today that Jeff Borcherding, CEO of Immunovia, has purchased 350 000 shares for approximately 670 KSEK. His total holding now amounts to 350 000 shares and 100 000 warrants in Immunovia.  About Immunovia Immunovia is a diagnostic company with the vision to revolutionize … Read more

Chief Executive Officer, Jeff Borcherding, buys Immunovia shares

LUND, Sweden, June 9, 2023 /PRNewswire/ — Immunovia AB (Nasdaq: IMMNOV) announces today that Jeff Borcherding, CEO of Immunovia, has purchased 350 000 shares for approximately 670 KSEK. His total holding now amounts to 350 000 shares and 100 000 warrants in Immunovia.  About Immunovia Immunovia is a diagnostic company with the vision to revolutionize … Read more

Changes to the Nomination Committee’s proposal to the Annual General Meeting 2023 in Immunovia AB (publ)

LUND, Sweden, May 22, 2023 /PRNewswire/ — Immunovia AB (publ) (“Immunovia“) published the notice to the Annual General Meeting 2023 on 25 April 2023 together with the Nomination Committee’s motivated statement which included the Nomination Committee’s proposals for board members. The Nomination Committee has now been informed that Helge Lubenow, Sven Andréasson and Vanessa Rollings … Read more